Leukemogenesis of Adult T-Cell Leukemia

International Journal of Hematology

Volumn 78, Issue 4, 2003, Pages 312-320

  Yasunaga, Jun Ichirou ^a   Matsuoka, Masao ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Adult T cell leukemia; Clonal expansion; Human T cell leukemia virus type I; Multistep leukemogenesis; Provirus

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; HLA ANTIGEN; PROTEIN P12; PROTEIN P53; TAX PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

CELL CYCLE; CELL PROLIFERATION; DNA MICROARRAY; GENE EXPRESSION; HAPLOTYPE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE SYSTEM; LEUKEMIA; LEUKEMIA CELL; LEUKEMOGENESIS; NONHUMAN; REVIEW; T CELL LEUKEMIA; VIRUS LOAD; VIRUS MORPHOLOGY;

EID: 0346219428     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02983555     Document Type: Review

References (97)

1. Takatsuki K, Uchiyama T, Sagawa K, Yodoi J. Adult T-cell leukemia in Japan. In: Seno S, Takaku F, Irino S, eds. Topics in Hematology, the 16th International Congress of Hematology, 1976, Kyoto, Japan. Amsterdam, the Netherlands: Excerpta Medica; 1977:73-77.
2. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481-492.
3. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77:7415-7419.
4. Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA. 1981;78:6476-6480.
5. Matsuoka M. Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene. 2003;22:5131-5140.
6. Seiki M, Hattori S, Hirayama Y, Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci U S A. 1983;80:3618-3622.
7. Aldovini A, De Rossi A, Feinberg MB, Wong-Staal F, Franchini G. Molecular analysis of a deletion mutant provirus of type I human T-cell lymphotropic virus: evidence for a doubly spliced x-lor mRNA. Proc Natl Acad Sci U S A. 1986;83:38-42.
8. Albrecht B, Lairmore MD. Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis. Microbiol Mol Biol Rev. 2002;66:396-406.
9. Yoshida M. Multiple viral strategies of HTLV-1, for dysregulation of cell growth control. Annu Rev Immunol. 2001;19:475-496.
10. Fujii M, Iwai K, Oie M, et al. Activation of oncogenic transcription factor AP-1 in T-cells infected with human T-cell leukemia virus type 1. AIDS Res Hum Retroviruses. 2000;16:1603-1606.
11. Mori N, Morishita M, Tsukazaki T, et al. Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor β signaling through interaction with CREB-binding protein/p300. Blood. 2001;97:2137-2144.
12. Lee DK, Kim BC, Brady JN, Jeang KT, Kim SJ. Human T-cell lymphotropic virus type 1 Tax inhibits transforming growth factor-β signaling by blocking the association of Smad proteins with Smad-binding element. J Biol Chem. 2002;277:33766-33775.
13. Ding W, Albrecht B, Luo R, et al. Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin. J Virol. 2001;75: 7672-7682.
14. Collins ND, Newbound GC, Albrecht B, Beard JL, Ratner L, Lairmore MD. Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. Blood. 1998;91: 4701-4707.
15. Albrecht B, Collins ND, Burniston MT, et al. Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes. J Virol. 2000;74: 9828-9835.
16. Ding W, Albrecht B, Kelley RE, et al. Human T-cell lymphotropic virus type 1 p12(I) expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T-cells. J Virol. 2002;76:10374-10382.
17. Bartoe JT, Albrecht B, Collins ND, et al. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J Virol. 2000;74:1094-1100.
18. Edlich RF, Arnette JA, Williams FM. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med. 2000;18: 109-119.
19. Arisawa K, Soda M, Endo S, et al. Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer. 2000;85: 319-324.
20. Takatsuki K, Yamaguchi K, Matsuoka M. ATL and HTLV-I-related diseases. In: Takatsuki K, ed. Adult T-Cell Leukemia. New York, NY: Oxford University Press; 1994:1-27.
21. Hanchard B. Adult T-cell leukemia/lymphoma in Jamaica: 1986-1995. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(suppl 1):S20-S25.
22. Okamoto T, Ohno Y, Tsugane S, et al. Multi-step carcinogenesis model for adult T-cell leukemia. Jpn J Cancer Res. 1989;80:191-195.
23. Seiki M, Eddy R, Shows TB, Yoshida M. Nonspecific integration of the HTLV provirus genome into adult T-cell leukaemia cells. Nature. 1984;309:640-642.
24. Etoh K, Yamaguchi K, Tokudome S, et al. Rapid quantification of HTLV-I provirus load: detection of monoclonal proliferation of HTLV-I-infected cells among blood donors. Int J Cancer. 1999;81: 859-864.
25. Iga M, Okayama A, Stuver S, et al. Genetic evidence of transmission of human T-cell lymphotropic virus type 1 between spouses. J Infect Dis. 2002;185:691-695.
26. Etoh K, Tamiya S, Yamaguchi K, et al. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res. 1997;57:4862-4867.
27. Cavrois M, Leclercq I, Gout O, Gessain A, Wain-Hobson S, Wattel E. Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with tropical spastic paraparesis/HTLV-1 associated myelopathy. Oncogene. 1998;17:77-82.
28. Sakashita A, Hattori T, Miller CW, et al. Mutations of the p53 gene in adult T-cell leukemia. Blood. 1992;79:477-480.
29. Cesarman E, Chadburn A, Inghirami G, Gaidano G, Knowles DM. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations. Blood. 1992;80:3205-3216.
30. Nishimura S, Asou N, Suzushima H, et al. p53 gene mutation and loss of heterozygosity are associated with increased risk of disease progression in adult T-cell leukemia. Leukemia. 1995;9:598-604.
31. Hatta Y, Hirama T, Miller CW, Yamada Y, Tomonaga M, Koeffler HP. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood. 1995;85:2699-2704.
32. Uchida T, Kinoshita T, Watanabe T, et al. The CDKN2 gene alterations in various types of adult T-cell leukaemia. Br J Haematol. 1996;94:665-670.
33. Nosaka K, Maeda M, Tamiya S, Sakai T, Mitsuya H, Matsuoka M. Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia. Cancer Res. 2000;60: 1043-1048.
34. Morosetti R, Kawamata N, Gombart AF, et al. Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood. 1995;86:1924-1930.
35. Hatta Y, Yamada Y, Tomonaga M, Koeffier HP. Extensive analysis of the retinoblastoma gene in adult T-cell leukemia/lymphoma (ATL). Leukemia. 1997;11:984-989.
36. Takeuchi S, Takeuchi N, Tsukasaki K, et al. Mutations in the retinoblastoma-related gene RB2/p130 in adult T-cell leukaemia/ lymphoma. Leuk Lymphoma. 2003;44:699-701.
37. Tamiya S, Etoh K, Suzushima H, Takatsuki K, Matsuoka M. Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells. Blood. 1998;91:3935-3942.
38. Maeda T, Yamada Y, Moriuchi R, et al. Fas gene mutation in the progression of adult T-cell leukemia. J Exp Med. 1999;189: 1063-1071.
39. Miyamoto Y, Yamaguchi K, Nishimura H, et al. Familial adult T-cell leukemia. Cancer. 1985;55:181-185.
40. Tsukasaki K, Miller CW, Kubota T, et al. Tumor necrosis factor α polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers. Cancer Res. 2001;61:3770-3774.
41. Wano Y, Feinberg M, Hosking JB, Bogerd H, Greene WC. Stable expression of the Tax gene of type I human T-cell leukemia virus in human T-cells activates specific cellular genes involved in growth. Proc Natl Acad Sci U S A. 1988;85:9733-9737.
42. Muraoka O, Kaisho T, Tanabe M, Hirano T. Transcriptional activation of the interleukin-6 gene by HTLV-1 p40tax through an NF-kappa B-like binding site. Immunol Lett. 1993;37:159-165.
43. Azimi N, Brown K, Bamford RN, Tagaya Y, Siebenlist U, Waldmann TA. Human T-cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-κB site. Proc Natl Acad Sci U S A. 1998;95:2452-2457.
44. Himes SR, Coles LS, Katsikeros R, Lang RK, Shannon MF. HTLV-1 tax activation of the GM-CSF and G-CSF promoters requires the interaction of NF-κB with other transcription factor families. Oncogene. 1993;8:3189-3197.
45. Ballard DW, Bohnlein E, Lowenthal JW, Wano Y, Franza BR, Greene WC. HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene. Science. 1988; 241:1652-1655.
46. Fujii M, Sassone-Corsi P, Verma IM. c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I. Proc Natl Acad Sci USA. 1988;85:8526-8530.
47. Fujii M, Niki T, Mori T, et al. HTLV-1 Tax induces expression of various immediate early serum responsive genes. Oncogene. 1991; 6:1023-1029.
48. Cereseto A, Diella F, Mulloy JC, et al. p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/ leukemia virus type I-transformed T-cells. Blood. 1996;88: 1551-1560.
49. Akagi T, Ono H, Shimotohno K. Expression of cell-cycle regulatory genes in HTLV-1 infected T-cell lines: possible involvement of Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1/ Cip1/Sdi1. Oncogene. 1996;12:1645-1652.
50. Iwanaga R, Ohtani K, Hayashi T, Nakamura M. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. Oncogene. 2001;20: 2055-2067.
51. L expression by human T-cell leukemia virus type 1 Tax through NF-κB in apoptosis-resistant T-cell transfectants with Tax. J Virol. 1999; 73:7981-7987.
52. Mamane Y, Sharma S, Grandvaux N, Hernandez E, Hiscott J. IRF-4 activities in HTLV-I-induced T-cell leukemogenesis. J Interferon Cytokine Res. 2002;22:135-143.
53. Hayashibara T, Yamada Y, Mori N, et al. Possible involvement of aryl hydrocarbon receptor (AhR) in adult T-cell leukemia (ATL) leukemogenesis: constitutive activation of AhR in ATL. Biochem Biophys Res Commun. 2003;300:128-134.
54. Jeang KT, Widen SG, Semmes OJ 4th, Wilson SH. HTLV-I trans-activator protein, Tax, is a trans-repressor of the human beta-polymerase gene. Science. 1990;247:1082-1084.
55. Lemasson I, Robert-Hebmann V, Hamaia S, Duc Dodon M, Gazzolo L, Devaux C. Transrepression of lck gene expression by human T-cell leukemia virus type 1-encoded p40tax. J Virol. 1997; 71:1975-1983.
56. Suzuki T, Uchida-Toita M, Yoshida M. Tax protein of HTLV-1 inhibits CBP/p300-mediated transcription by interfering with recruitment of CBP/p300 onto DNA element of E-box or p53 binding site. Oncogene. 1999;18:4137-4143.
57. Ruckes T, Saul D, Van Snick J, Hermine O, Grassmann R. Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309. Blood. 2001;98:1150-1159.
58. Fujii K, Ishimaru F, Nakase K, et al. Over-expression of short isoforms of Helios in patients with adult T-cell leukaemia/lymphoma. Br J Haematol. 2003;120:986-989.
59. Kiyokawa T, Yamaguchi K, Takeya M, et al. Hypercalcemia and osteoclast proliferation in adult T-cell leukemia. Cancer. 1987;59: 1187-1191.
60. Arai F, Miyamoto T, Ohneda O, et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors. J Exp Med. 1999;190:1741-1754.
61. Nosaka K, Miyamoto T, Sakai T, Mitsuya H, Suda T, Matsuoka M. Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor κB ligand on adult T-cell leukemia cells. Blood. 2002;99:634-640.
62. Wano Y, Hattori T, Matsuoka M, et al. Interleukin 1 gene expression in adult T-cell leukemia. J Clin Invest. 1987;80:911-916.
63. Niitsu Y, Urushizaki Y, Koshida Y, et al. Expression of TGF-β gene in adult T-cell leukemia. Blood. 1988;71:263-266.
64. Watanabe T, Yamaguchi K, Takatsuki K, Osame M, Yoshida M. Constitutive expression of parathyroid hormone-related protein gene in human T-cell leukemia virus type 1 (HTLV-1.) carriers and adult T-cell leukemia patients that can be trans-activated by HTLV-1 tax gene. J Exp Med. 1990;172:759-765.
65. Harhaj EW, Good L, Xiao G, Sun SC. Gene expression profiles in HTLV-1-immortalized T-cells: deregulated expression of genes involved in apoptosis regulation. Oncogene. 1999;18:1341-1349.
66. de La Fuente C, Deng L, Santiago F, Arce L, Wang L, Kashanchi F. Gene expression array of HTLV type 1-infectedT-cells: up-regulation of transcription factors and cell cycle genes. AIDS Res Hum Retroviruses. 2000;16:1695-1700.
67. Ng PW, Iha H, Iwanaga Y, et al. Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-κB activation. Oncogene. 2001; 20:4484-4496.
68. Pise-Masison CA, Radonovich M, Mahieux R, et al. Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes. Cancer Res. 2002;62: 3562-3571.
69. Wodarz D, Hall SE, Usuku K, et al. Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1. Proc R Soc Lond B Biol Sci. 2001; 268:1215-1221.
70. Borg A, Yin JA, Johnson PR, Tosswill J, Saunders M, Morris D. Successful treatment of HTLV-1-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation. Br J Haematol. 1996;94:713-715.
71. Utsunomiya A, Miyazaki Y, Takatsuka Y, et al. Improved outcome of adult T-cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;27:15-20.
72. Hoshida Y, Li T, Dong Z, et al. Lymphoproliferative disorders in renal transplant patients in Japan. Int J Cancer. 2001;91:869-875.
73. + cytotoxic T lymphocytes. AIDS Res Hum Retroviruses. 2001; 17:1047-1061.
74. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature. 1990;348: 245-248.
75. + cytotoxic T-cells directed against HTLV-I-infected cells. Int Immunol. 1991;3:761-767.
76. Tamiya S, Matsuoka M, Etoh K, et al. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood. 1996;88:3065-3073.
77. Furukawa Y, Kubota R, Tara M, Izumo S, Osame M. Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia. Blood. 2001;97:987-993.
78. Koiwa T, Hamano-Usami A, Ishida T, et al. 5′-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo. J Virol. 2002;76:9389-9397.
79. Kibler KV, Jeang KT. Taxing the cellular capacity for repair: human T-cell leukemia virus type 1, DNA damage, and adult T-cell leukemia. J Natl Cancer Inst. 1999;91:903-904.
80. White JD, Zaknoen SL, Kasten-Sportes C, et al. Infectious complications and immunodeficiency in patients with human T-cell lymphotropic virus I-associated adult T-cell leukemia/lymphoma. Cancer. 1995;75:1598-1607.
81. Katsuki T, Katsuki K, Imai J, Hinuma Y. Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-I): impairment of T-cell control of Epstein-Barr virus-infected B-cells. Jpn J Cancer Res. 1987;78:639-642.
82. Sadahira Y, Nishihara H, Shimizu M, et al. Epstein-Barr virus-associated Hodgkin's disease in HTLV-I seropositive patients: a report of two cases. Pathol Int. 1998;48:67-73.
83. Welles SL, Tachibana N, Okayama A, et al. Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status. Int J Cancer. 1994;56:337-340.
84. Yasunaga J, Sakai T, Nosaka K, et al. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. Blood. 2001; 97:3177-3183.
85. + T-cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood. 2001;98:1858-1861.
86. + T lymphocytes naturally infected with human T-cell lymphotropic virus type I. Immunity. 2000;13:657-664.
87. Kannagi M, Ohashi T, Hanabuchi S, et al. Immunological aspects of rat models of HTLV type 1-infected T lymphoproliferative disease. AIDS Res Hum Retroviruses. 2000;16:1737-1740.
88. Ohshima K, Haraoka S, Yoshioka S, et al. Mutation analysis of mitotic checkpoint genes (hBUBT1 and hBUBR1) and microsatellite instability in adult T-cell leukemia/lymphoma. Cancer Lett. 2000;158:141-150.
89. Yamada Y, Sugawara K, Hata T, et al. Interleukin-15 (IL-15) can replace the IL-2 signal in IL-2-dependent adult T-cell leukemia (ATL) cell lines: expression of IL-15 receptor α on ATL cells. Blood. 1998;91:4265-4272.
90. Yoshie O, Fujisawa R, Nakayama T, et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T-cells. Blood. 2002;99:1505-1511.
91. Hasegawa H, Nomura T, Kohno M, et al. Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells. Blood. 2000;95:30-38.
92. Arai M, Ohashi T, Tsukahara T, et al. Human T-cell leukemia virus type 1 Tax protein induces the expression of lymphocyte chemoattractant SDF-1/PBSF. Virology. 1998;241:298-303.
93. Mori N, Nunokawa Y, Yamada Y, Ikeda S, Tomonaga M, Yamamoto N. Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells. Blood. 1999;94: 2862-2870.
94. Mori N, Sato H, Hayashibara T, et al. Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness. Blood. 2002;99:1341-1349.
95. Miura S, Ohtani K, Numata N, et al. Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax. Mol Cell Biol. 1991;11:1313-1325.
96. Imura A, Hori T, Imada K, et al. OX40 expressed on fresh leukemic cells from adult T-cell leukemia patients mediates cell adhesion to vascular endothelial cells: implication for the possible involvement of OX40 in leukemic cell infiltration. Blood. 1997;89: 2951-2958.
97. Brauweiler A, Garrus JE, Reed JC, Nyborg JK. Repression of bax gene expression by the HTLV-1 Tax protein: implications for suppression of apoptosis in virally infected cells. Virology. 1997;231: 135-140.